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Various diseases are caused by defective genes or 
mutations within the DNA. These mutations can 
cause cancer cells, which are usually treated 
through chemotherapy and radiation. However, 
these methods have not completely effective 
towards cancer stem cells, a group of cancer cells 
that possess stem cell properties and are capable of 
initiating cancer. In order to discover new methods 
of targeting these specific cells, technology for 
genome engineering will enable researchers to 
further study genetic requirements within these 
cells. The method of clustered regularly interspaced 
short palindromic repeats (CRISPR)-Cas9 will help 
cleave and alter genomic sequences to potentially 
correct the genomic mutations caused by the cancer 
stem cell. Using the technology of CRISPR-Cas9, 
studies of these cells and growth requirements can 
help discover new ways to target the cancer stem 
cell as a new method of therapy. 
 Cells will express lenticas9-blast, selected for 
blasticidin in the same cancer cell as the guide 
vectors selected for Puro.8
 Both gRNAs will anneal with the DNA templates 
at two locations of the target gene.
 The Cas9 endonuclease will cut on RNA DNA 
loci on the target DNA template to delete 
fragment in between the gRNAs.8
 Obtain Cell Clones 
 Single cell clones with the deleted copies will be 
marked and be obtained by serial cell dilution. 
 Verification of the deletion clones are made by 
observing appearance of gene deletion such as 
PCR or protein detection.8
The current research is on the roles of protein by post-
translational modifications in cancer stem cells by 
generating a gene knockout mutation of genes that 
encode modifying activities involved in maintenance of 
cancer stem cells. This will lead to further studies of 
protein interactions in order to learn about the 
pathways within cancer cells. Due to this, researchers 
will be able to identify the mechanism that control the 
division of cancer cells. Based on the research, the 
development or discovery of a chemical inhibitor can 
be made. 
The approach of this research can be completed by 
creating model cell lines to determine closely related 
gene functions and to find a way in correcting any 
genomic changes.3 Numerous diseases, such as 
cancer in this case, are caused by a defective gene 
which can be a result even from a mutation in a single 
nucleotide.6
The development of genomic surgery is an approach 
that will be more specific to patients’ method of 
treatment.1 In order to target these mutations directly, 
studies are done by precisely cutting the target 
nucleotide sequence.6 The type II clustered regularly 
interspaced short palindromic repeats (CRISPR) 
system uses a single endonuclease, Cas9. The 
enzyme cooperates with the guide RNA to specifically 
cleave invading DNA at sites separated by the proto-
spacer adjacent motifs (PAMs).2 The single guide RNA 
will program the Cas9 to create double strand breaks 
in the targeted DNA strand, making the specific cuts to 
further study the mutated proteins in the experiment.2
 Western Blot 
• Separate according to size, transfer to a solid 
support, and then mark the target protein using a 
proper primary and secondary antibody to view 
the results.5 The results will help indicate which 
cell is expressing the protein in order to focus 
more on the interaction.
Figure 2: One-Color Workflow for Quantative
Infrared Westerns: General steps in completing a 
Western Blot procedure.5
 DNA Electrophoresis 
• DNA is separated by their length in base pairs. 
• The electrophoresis uses an electrical current to 
move the negatively charged DNA toward the 
positively charge area within the agarose gel 
created. 
Developing an understanding and having the ability 
to assist in the process of forming a chemical 
inhibitor to treat diseases; in this case, cancer stem 
cell research can have a huge beneficial impact on 
this world. If there can be a new target of therapy 
towards cancer stem cells specifically, it can 
decrease the amount of damage to normal cells 
when patients undergo therapy. 
Chemotherapy treatment does not guarantee a 
complete recovery and the small percentage of 
cancer stem cells that may exist could multiply within 
the next few years. Discovering a chemical inhibitor 
for treatment of therapy could be a safer and more 
effective alternative. 
Due to the status of this research, no specific 
therapy or chemical inhibitor have been found. In 
order to reach this long term goal, the knock out 
cells’ protein interaction and pathways must be 
closely studied in order to identify a target of therapy. 
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Figure 1: “Target Guide Sequence Cloning Protocol: In order 
to clone target sequence into the lentiGuide-Puro backbone, 
two oligonucleotides are synthesized. All plasmids will have 
same overhangs BsmBI digestion, therefore the 
oligonucleotides can be cloned into lentiCRISPRv2, 
lentiCRISPRv1, or lentiGuide-Puro.” – ZhangLab8
 Aseptic Technique 
 This technique minimizes number of 
contaminants in the laboratory.7
 All surfaces and materials must be disinfected 
by spraying alcohol such as isopropanol or 
70% ethanol while wearing proper equipment.7 
 A Bunsen burner is ignited and must be 
adjusted so a blue cone appears on the flame 
to ensure the highest  temperature is reached.7
The heat created by the flame will rise up and 
cause microorganisms and dust particles to be 
forced outside of the sterile fume hood.7
 Heat all materials, which includes pipette tips, 
caps, bottles, and any other equipment that 
may cause contamination, before and after use. 
 Generate CRISPR Guide RNA into a plasmid for 
transfection into cells 
 2 pairs of 20 oligonucleotides are designed and 
synthesized based 2 pairs NGG PAM sequence 
on DNA template sequence of targeted genes.8
These pairs of oligonucleotides are made for 
two gRNAs. The process is performed twice, 
where oligo 3 and 4 are made for a different 
segment in the target gene with the PAM 
sequence. 
 Target guide sequences are then cloned into 
the plasmid DNA carrier, the vector known as 
lentiGuide-Puro.8  
 Transfection Process
 Using Puromycin drug for cells expressing 
Puro, transfect the guide-vectors in the cancer 
cells.8
 Cells will begin expressing the gRNA 1 from 
oligos 1 and 2 vector and gRNA 2 from oligos 3 
and 4 vector. 
